Grifols SA (GRFS)
8.59
0.00 (0.00%)
USD |
NASDAQ |
Mar 06, 16:00
8.59
0.00 (0.00%)
After-Hours: 20:00
Grifols EPS Diluted (Quarterly) : 0.168 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Akari Therapeutics Plc | -0.1947 |
| Pharma Mar SA | 3.978 |
| Oryzon Genomics SA | -0.0202 |
| Evaxion AS | -0.2862 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 146.39M |
| Revenue (Quarterly) | 2.307B |
| Total Expenses (Quarterly) | 2.192B |
| Enterprise Value | 17.89B |
| Gross Profit Margin (Quarterly) | 34.66% |
| Profit Margin (Quarterly) | 6.35% |
| Earnings Yield | 7.85% |
| Operating Earnings Yield | 24.23% |
| Normalized Earnings Yield | 7.492 |